Tris[1-phenylisoquinoline-C2,N]iridium(III) (purified by sublimation)>99.0%(HPLC)100mg

4-(3-chlorophenyl)-1H-pyrazol-5-amine, 95.0%, 5g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, 95+%, 1g

3',4'-dimethyl-3-(4-methylphenyl)propiophenone, 97.0%, 1g

3-Oxo-3,4-dihydro-2H-1,4-benzoxazine-6-carboxylic acid, 97.0%, 1g

2-Amino-4-(trifluoromethyl)benzonitrile, 95.0%, 5g

4-(Aminomethyl)-3-fluorobenzonitrile, 97.0%, 250mg

tert-Butyl 2-((2-hydroxyethyl)amino)acetate, 95%, 250mg

5-Chloro-1H-pyrrolo[2,3-c]pyridine-3-carbonitrile, 97%, 5g

5-(1,1-Dimethyl-heptyl)resorcinol, 95.0%, 25g

4-BROMO-5-FLUORO-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 10g

5-Benzyl-4-ethyl-4H-[1,2,4]triazole-3-thiol, 95.0%, 10g

2,4-Bis(benzyloxy)-6-chloro-1,3,5-triazine, 95% HPLC,T, 5g